Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TKPHF) Return on Assets (2018 - 2025)

Historic Return on Assets for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to 0.14%.

  • Takeda Pharmaceutical's Return on Assets rose 300.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.01% for FY2025, which is 0.0% changed from last year.
  • Per Takeda Pharmaceutical's latest filing, its Return on Assets stood at 0.14% for Q4 2025, which was up 300.0% from 0.15% recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Return on Assets high stood at 0.15% for Q2 2025, and its period low was 0.03% during Q2 2023.
  • Its 5-year average for Return on Assets is 0.07%, with a median of 0.06% in 2021.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -300bps in 2023, then skyrocketed by 900bps in 2025.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Return on Assets stood at 0.05% in 2021, then decreased by -15bps to 0.05% in 2022, then skyrocketed by 36bps to 0.06% in 2023, then surged by 70bps to 0.11% in 2024, then soared by 33bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q4 2025, 0.15% for Q3 2025, and 0.15% during Q2 2025.